Jorn Kaspers

Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

Lennart Holterman, Ronald Vogels, Remko van der Vlugt et al. · Journal of Virology · 2004 · 143 citations · Full text

Viral Replication, Immunology, Pathology +17

Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa

Anna R. Thorner, Ronald Vogels, Jorn Kaspers et al. · Journal of Clinical Microbiology · 2006 · 112 citations · Full text

Vaccination, Antibody Titers, Viral Persistence +14

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells

Menzo Havenga, Ronald Vogels, David Zuijdgeest et al. · Journal of General Virology · 2006 · 95 citations

Viral Replication, Viral Polymerase Mechanism, Immunology +18

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Arjan A. van de Loosdrecht, Sandra van Wetering, Saskia J. Santegoets et al. · Cancer Immunology Immunotherapy · 2018 · 86 citations · Full text

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity

Menzo Havenga, Lennart Holterman, Irene Melis et al. · Biotechnology and Bioengineering · 2007 · 43 citations · Full text

Viral Replication, Adenoviral Vector, Engineering +21